Selective serotonin reuptake inhibitors (SSRI) have been reported to improve depression in advanced cancer (Holland et al, 1998), and in melanoma treated with interferon α (Musselman et al, 2001) since the latter also upregulates IDO (Taylor and Feng, 1991). Here, IDO1 is linked to melanoma.